Two rewards you can earn:
Patient Advocate Foundation's Co-Pay Relief program exists to help reduce the financial distress patients, and their families face when paying for treatment. Drivers presonus usb devices. We believe that no patient should go without life changing medications because they cannot afford them. Start Saving with the RYTARY Co-Pay Savings Card. If you have commercial insurance, you may be eligible to:. Pay as little as $25 for your first RYTARY prescription. Pay as little as $0 if you're written a second or third prescription of RYTARY within that same 30-day period†.Maximum benefit of $100. †The Rytary Co-Pay Savings Card is not valid for prescriptions submitted for reimbursement.
- Free PCP visits:
- To earn free PCP visits, select a PCP, and
- Complete the RealAge® test (an online health assessment that helps you determine the physical age of your body compared to your calendar age.)
- $5 reduction to your specialist copay:
- To receive a $5 reduction in your specialist copay, complete one of the recommended screenings listed in the State of Maryland Wellness Plan Activities (PDF).
The $5 reduction to your specialist copay will be activated after CareFirst receives a verified paid claim. The claim must meet certain requirements including having gone through the CareFirst claims review process and have been paid. CareFirst will update the member's account to show the $5 copay reduction has been granted. The entire process may take up to 45 days.
To access the above activities, simply log in to your Sharecare account, click Achieve, then Rewards. Next, click State of Maryland Wellness Program 2021. The sooner you complete your wellness plan activities, the sooner you start saving. If you require assistance with the wellness program or completing any activity, call Sharecare at 877-260-3253.
*Sharecare, Inc. is an independent company that provides health improvement management services to CareFirst members. Sharecare, Inc. does not provide CareFirst BlueCross BlueShield products or services and is solely responsible for the health improvement management services it provides.
Patient Eligibility Requirements*
- Patient must be prescribed BLINCYTO® (blinatumomab), IMLYGIC® (talimogene laherparepvec), KANJINTI™ (trastuzumab-anns), KYPROLIS® (carfilzomib), MVASI™ (bevacizumab-awwb), Neulasta® (pegfilgrastim), Neulasta® Onpro®, NEUPOGEN® (filgrastim), Nplate® (romiplostim), Prolia® (denosumab), RIABNI™ (rituximab-arrx), Vectibix® (panitumumab), or XGEVA® (denosumab).
- Must have private commercial health insurance that covers medication costs for BLINCYTO®, IMLYGIC®, KANJINTI™, KYPROLIS®, MVASI™, Neulasta®, Neulasta® Onpro®, NEUPOGEN®, Nplate®, Prolia®, RIABNI™, Vectibix®, or XGEVA®.
- Must not be a participant in any federal-, state-, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TriCare.
- May not seek reimbursement for value received from the Amgen FIRST STEP™ Program from any third-party payers, including flexible spending accounts or healthcare savings accounts. If at any time patients begin receiving coverage under any federal-, state-, or government-funded healthcare program, patients will no longer be eligible to participate in the Amgen FIRST STEP™ Program and must call 1-888-65-STEP1 (1-888-657-8371) Monday through Friday, 9 AM-8 PM EST to stop participation. Restrictions may apply. This is not health insurance. Program invalid where otherwise prohibited by law.
* Other restrictions apply. If you become aware that your health plan or pharmacy benefit manager does not allow the use of manufacturer co-pay support as part of your health plan design, you agree to comply with your obligations, if any, to disclose your use of the card to your insurer. Amgen reserves the right to revise or terminate this program, in whole or in part, without notice at any time.
Coverage Limits/Program Maximums
- Program covers out-of-pocket medication costs for the Amgen product only. Program does not cover any other costs related to office visit or administration of the Amgen product. Patient is responsible for costs above the maximum benefit amounts detailed below.
- For Neulasta®, Neulasta® Onpro®, NEUPOGEN®, Nplate®, XGEVA®, Vectibix®, IMLYGIC®, and BLINCYTO®: no out-of-pocket cost for first dose or cycle; $5 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $10,000 per patient per calendar year.
- For KANJINTI™, KYPROLIS®, MVASI™, and RIABNI™: no out-of-pocket cost for first dose or cycle; $5 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $20,000 per patient per calendar year.
- For Prolia®: no out-of-pocket cost for first dose or cycle; $25 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $1,500 per patient per calendar year.
- Ongoing activation of the Amgen FIRST STEP™ card is contingent on the submission of the required Explanation of Benefits (EOB) form by the healthcare provider's office within 45 days of use of the Amgen FIRST STEP™ card. Patients will be responsible for reimbursing the program for all amounts paid out if the EOB for the date of service is not received within 45 days.
Is Patient First Covered By Insurance
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for BLINCYTO®.
Please see Full Prescribing Information, including Boxed WARNINGS, for KANJINTI™.
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for RIABNI™
Please see Full Prescribing Information, including Boxed WARNINGS, for Vectibix®.